CMS WISeR documentation checklist · §6.2.9
Operational Guide v7.0, last updated July 24, 2026 · retrieved 2026-09-14
Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF) (L34228, L38201, L35130)
CMS: “To meet coverage criteria, the patient’s medical record must contain documentation that fully supports the medical necessity of services. Subsections 6.2.1 to 6.2.13 list the documentation requirements for example services. For detailed documentation requirements, providers who choose to submit a prior authorization request for a WISeR Select Item or Service should refer to the relevant NCDs and/or their MAC jurisdiction’s LCDs and Local Coverage Articles (LCAs), if available, for guidance. They can be found on the Medicare Coverage Database website.”
General documentation requirements for Percutaneous Vertebroplasty Augmentation (PVA) (Percutaneous Vertebroplasty [PVP] or Kyphoplasty [PKP]) are as follows:
- For painful, debilitating, osteoporotic, vertebral, collapse/compression fractures, the following requirements should be met: a) Acute (less than 6 weeks) or subacute (6 to 12 weeks) osteoporotic VCF (T1–L5) based on symptom onset and documented by advanced imaging (bone marrow edema on MRI or bone-scan/single-photon emission computed tomography (SPECT)/computed tomography (CT) uptake) b) Hospitalized with severe pain, defined as a Numeric Rating Scale (NRS) or Visual Analog Scale (VAS) pain score greater than or equal to 8 OR non-hospitalized with moderate to severe pain, defined as a NRS or VAS pain score greater than or equal to 5, despite optimal non-surgical management (e.g., narcotic and/or non-narcotic medication, physical therapy modalities), with and without methods of immobility (e.g., rest, bracing). For non-hospitalized patients, one of the following must be documented: o Worsening pain OR o Stable to improved pain (but NRS or VAS score remains greater than or equal to 5), with at least 2 of the following: 1. Progression of vertebral body height loss 2. More than 25% vertebral body height reduction 3. Kyphotic deformity 4. Severe impact of VCF on daily functioning, indicated by a Roland Morris Disability Questionnaire (RDQ) score greater than 17 c) Documentation of referral for evaluation of bone mineral density and osteoporosis education for subsequent treatment as indicated d) Documentation of instruction to participate in an osteoporosis prevention/treatment program
- For malignant vertebral fracture, documentation that the patient has an osteolytic vertebral, metastasis, or myeloma with severe back pain related to a destruction of the vertebral body, not involving the major part of the cortical bone
- Assessment and documentation of none of the following: a) Current back pain is not primarily due to the identified acute or subacute VCF(s) b) Osteomyelitis, discitis, or active systemic or surgical site infection c) Pregnancy
- Assessment of the following relative contraindications and rationale for proceeding with PVA if one or more of the following exist: a) Greater than three vertebral fractures per procedure b) Allergy to bone cement or opacification agents c) Uncorrected coagulopathy d) Spinal instability e) Myelopathy from the fracture f) Neurologic deficit g) Neural impingement h) Fracture retropulsion/canal compromise